Johnson & Johnson is a diversified healthcare giant. J&J has increased its dividend for 63 consecutive years. One high-yield ...

Johnson & Johnson denied wrongdoing after a conservative watchdog group accused the company of violating federal equal ...

Johnson & Johnson said the first clinical data from its ongoing Phase 1b study of JNJ-4496, a chimeric antigen receptor T-cell therapy, shows encouraging potential in treating large B-cell lymphoma, ...